University of Missouri-Columbia
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, University of Missouri-Columbia sits in the top decile of US sponsors by registered trial count (#120 of 15,742 sponsors by registered trial count).
University of Missouri-Columbia: 291 sponsored US clinical trials, 54 recruiting.
University of Missouri-Columbia sponsors 291 registered US clinical trials on ClinicalTrials.gov, 54 of them currently recruiting, and 170 completed. 29 of these trials are in Phase 3-4 (later-stage) and 38 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Obesity, with 8 trials.
Top-decile sponsor footprint
University of Missouri-Columbia ranks in the top decile of sponsors by registered trial count (#120 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
170 of 224 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (75.9%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
291 total, page 2 of 6
Outcomes of Low-Impact Exercise Program for People With Ankle, Knee, and/or Hip Pain
NCT03711773
Harnessing Neuroplasticity to Enhance Functional Recovery During Chronic Recovery From Upper Extremity Nerve Repair
NCT03610763
Tumor Cell and DNA Detection in the Blood, Urine and Bone Marrow of Patients With Solid Cancers
NCT02838836
Tumor Cell and DNA Detection in the Blood, Urine, and Bone Marrow
NCT03551951
Evaluating the Influence of Diet-induced Weight Loss on Fat (Adipose) Tissue's Insulin Sensitivity and Testosterone Synthesis in Women With Overweight or Obesity, Insulin Resistance, and Hyperandrogenemia
NCT06998238
This Study Consists of Two Study Parts Conducted Under a Single IRB. Part I: Short Term ApoE-dependent Cerebral Blood Flow Response to Sirolimus in Cognitively Normal Adults Part II: Short Term ApoE-dependent Cerebral Blood Flow and Lung Perfusion Response to Sirolimus in Cognitively Normal Adults
NCT05386914
ADAM17 and Vascular Function in Diabetes
NCT04557228
Effects of Pulse Consumption, Gut Microbiome, and Appetite in Healthy Participants
NCT07043712
Leucine, MTOR and Athero
NCT05470218
Sex Disparities in Hypoxic Sympatholysis and Impact of Obesity
NCT04436731
Sleep Intervention for Chronic Insomnia Using Virtual Reality Pilot Study
NCT04253691
Study of Fat Tissue's Ability to Take up Sugar in the Obese Population
NCT02994459
Growth Hormone Resistance of Beta-cells
NCT07581860
Interplay of Central and Peripheral Vascular Effects of Insulin in Obesity
NCT07653464
Beta3-adrenergic Receptors and Cardiovascular Function in Aging Women
NCT07674680
Metacognitive Strategy Training Intervention for Transition-Age Youth With Cerebral Palsy
NCT07424079
Talar Osteochondral Lesions With Pilon Fractures
NCT07553221
The Effect of Omega 3 Supplementation on Postoperative Delirium in Elderly Patients Undergoing Major Cardiac Surgery
NCT06434948
Effectiveness of and Implementation Strategies for 'Disfrutando'.
NCT07023406
Establishing Optimal PEEP Setting for Obese Patients in the Steep Trendelenburg Position
NCT06518239
Opioid Rapid Response System: Naloxone Training in Communities
NCT06238128
Impact of Negative Pressure Ventilation in Patients Hospitalized With Acute Hypercapnic Respiratory Failure
NCT06108284
Cognitive Rehabilitation in Post-COVID-19 Syndrome
NCT06136871
Sex-specific Effect of Restricted Sleep on Brain Health
NCT05920759
Adaptation and Implementation of a Cherokee-based Participatory Research Project to Reduce CVD Risk
NCT06671652
Symptom Based Performance of Airway Clearance After Starting Highly Effective Modulators for Cystic Fibrosis (SPACE-CF)
NCT05392855
CommitFit App to Facilitate Health Behavior Change in Clinic Adolescents
NCT06985251
Sugammadex vs Neostigmine/Glycopyrrolate on Urinary Retention After Spine Surgery
NCT05887375
The Drinking Dashboard Study
NCT05630625
Individualized Assessment of Motor Function and Balance in Intensive Therapy
NCT05820412
Sex-related Differences in Sympathetic Vascular Transduction in the Setting of Hypoxemia
NCT05256069
Conjoint Tendon Resection During Reverse Total Shoulder Arthroplasty
NCT05753904
Pain Rating Challenges and Patterns
NCT06115278
Biological Response to Platelet-rich Plasma and Corticosteroid Injections
NCT05657496
Metacognitive Strategy Training in Cancer-related Cognitive Impairment
NCT05505045
Zinc and Green Tea Extract for Community Respiratory Viral Infections
NCT04898023
Effects of Almonds on Immune Health and Responsiveness
NCT05530499
Sleep Restriction and Postprandial Lipemia
NCT05713370
PAL to Improve Oral Feeding for Infants With Chronic Lung Disease
NCT05446389
Reducing COVID-19 Related Disability in Rural Community-Dwelling Older Adults Using Smart Technology
NCT05379504
Preliminary Study of Brain Effects of Palynziq-Related Changes in Phenylalanine in Individuals With PKU
NCT05356377
NICU Oxygen Control Study
NCT04269161
Exploring the Experiences and Outcomes of a Summer Intensive Therapy Program- Mixed Methods Study
NCT05443763
Variability in Microbial Response to Dietary Fiber
NCT06023940
tDCS and Metacognitive Strategy Training in Stroke
NCT05248178
Sleep Timing on Energy Intake and Energy Expenditure
NCT05096585
Cognitive Training in Mild Cognitive Impairment
NCT04899089
Role of Neuraminidase Activity on Endothelial Dysfunction in Type 2 Diabetes
NCT04867707
Effect of Head Rotation on Efficacy of Face Mask Ventilation in Anesthetized Obese (BMI ≥ 35) Adults
NCT03876873
Efficacy of Surgical Diathermy in Eradicating Cutibacterium Acnes From Surgical Skin Incision During Shoulder Arthroplasty
NCT04608916
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 26 |
| Phase 2 | 12 |
| Phase 3 | 4 |
| Phase 4 | 25 |
Therapeutic Areas
What is open in the University of Missouri-Columbia pipeline
54 recruiting of 291 indexed (19% open); 170 completed (58%).
Phase mix: 29 late (III/IV) vs 38 early (I/II) (balanced across stages).
Top condition: Obesity (8 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Missouri-Columbia: open-pipeline peers nationwide
Peers matched on 291 registered trials and 19% open enrollment, not the therapeutic-area sidebar.
University of Missouri-Columbia sits below the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 291 trials (± recruiting share)
- Thomas Jefferson University · 292 trials · 18% recruiting
- University of Michigan Rogel Cancer Center · 292 trials · 15% recruiting
- Kaiser Permanente · 294 trials · 7% recruiting
- Eisai · 287 trials · 2% recruiting
Sponsors near 19% open enrollment (± trial volume)
- Arkansas Children's Hospital Research Institute · 19% recruiting · 97 trials
- Montefiore Medical Center · 19% recruiting · 345 trials
- Children's Hospital Medical Center, Cincinnati · 19% recruiting · 571 trials
- Mclean Hospital · 19% recruiting · 140 trials
Related
What to do with this University of Missouri-Columbia page
291 registered trials is a research-attention snapshot, not an endorsement of University of Missouri-Columbia or any single study.
- 54 of University of Missouri-Columbia's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Obesity is the condition University of Missouri-Columbia studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Obesity trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
University of Missouri-Columbia pipeline card: 291 registered trials from official public datasets.Report a data error.